文献速递头颈部肿瘤放疗

头颈癌放疗疗程时间对生存的影响

The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-09-06

基于美国国家癌症数据库19,531例舌、下咽、喉、口咽或扁桃体癌患者,评估放化疗时代放疗疗程时间(RTT)对总生存(OS)的影响。多因素分析显示,延长RTT与更差OS相关(HR 1.25;95%CI 1.14-1.37),加速RTT与更好OS相关(HR 0.84;95%CI 0.73-0.97)。在9,200例接受根治性同步放化疗的患者中,延长RTT仍与更差OS相关(HR 1.29;95%CI 1.11-1.50)。

要点

  • 延长RTT与头颈癌患者更差OS独立相关,同步放化疗背景下仍显著。
  • 加速RTT在总体人群与更好OS相关,但在同步放化疗亚组无显著关联。
  • 应继续将尽快完成放疗作为头颈恶性肿瘤管理的质量指标。

核心结论

  • 延长RTT与接受放疗的头颈癌患者更差OS相关,即使在同步放化疗背景下仍显著。

研究设计与样本

  • 利用美国国家癌症数据库识别舌、下咽、喉、口咽或扁桃体癌患者,共纳入19,531例。
  • RTT定义为首次放疗日期至末次放疗日期;根治性设置中延长RTT为>56天、加速为<47天、标准为47-56天;术后设置中延长为>49天、加速为<40天、标准为40-49天。
  • 采用χ2检验识别RTT预测因素,Kaplan-Meier法比较OS,Cox比例风险模型在已知合并症状态患者中分析OS。

主要发现

  • 12,987例(67%)为标准RTT,4,369例(34%)为加速RTT,2,165例(11%)为延长RTT。
  • 多因素分析中,相对标准RTT,加速RTT与更好OS相关(HR 0.84;95%CI 0.73-0.97),延长RTT与更差OS相关(HR 1.25;95%CI 1.14-1.37)。
  • 在9,200例(47%)接受根治性同步放化疗的患者中,相对标准RTT,延长RTT与更差OS相关(HR 1.29;95%CI 1.11-1.50),加速RTT与OS无显著关联(HR 0.76;95%CI 0.57-1.01)。

关键数值与推荐

  • 根治性放疗设置:延长RTT定义为>56天,加速RTT定义为<47天,标准RTT定义为47-56天。
  • 术后放疗设置:延长RTT定义为>49天,加速RTT定义为<40天,标准RTT定义为40-49天。

临床怎么用

  • 应继续将尽快完成放疗作为头颈恶性肿瘤管理的质量指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the impact of radiation treatment time (RTT) in head and neck cancers on overall survival (OS) in the era of chemoradiation. METHODS AND MATERIALS: Patients with diagnoses of tongue, hypopharynx, larynx, oropharynx, or tonsil cancer were identified by use of the National Cancer Database. RTT was defined as date of first radiation treatment to date of last radiation treatment. In the definitive setting, prolonged RTT was defined as >56 days, accelerated RTT was defined as <47 days, and standard RTT was defined as 47 to 56 days. In the postoperative setting, prolonged RTT was defined as >49 days, accelerated RTT was defined as <40 days, and standard RTT was defined as 40 to 49 days. We used χ2 tests to identify predictors of RTT. The Kaplan-Meier method was used to compare OS among groups. Cox proportional hazards model was used for OS analysis in patients with known comorbidity status. RESULTS: 19,531 patients were included; 12,987 (67%) had a standard RTT, 4,369 (34%) had an accelerated RTT, and 2,165 (11%) had a prolonged RTT. On multivariable analysis, accelerated RTT (hazard ratio [HR] 0.84; 95% confidence interval [CI] 0.73-0.97) was associated with an improved OS, and prolonged RTT (HR 1.25; 95% CI 1.14-1.37) was associated with a worse OS relative to standard RTT. When the 9,200 (47%) patients receiving definitive concurrent chemoradiation were examined, prolonged RTT (HR 1.29; 95% CI 1.11-1.50) was associated with a worse OS relative to standard RTT, whereas there was no significant association between accelerated RTT and OS (HR 0.76; 95% CI 0.57-1.01). CONCLUSION: Prolonged RTT is associated with worse OS in patients receiving radiation therapy for head and neck cancer, even in the setting of chemoradiation. Expeditious completion of radiation should continue to be a quality metric for the management of head and neck malignancies.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Shaikh T, Handorf EA, Murphy CT, et al. The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016. PMID: 27869097. doi:10.1016/j.ijrobp.2016.08.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。